Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.
 

Share

    


In This Section

Home / News & Media / News Template
Press Release Logo  
 

CONTACT:
Lori Gardner, Senior Director
Membership and Public Relations
301.984.9496 ext. 226


FOR IMMEDIATE RELEASE: Oct 26, 2016


Internationally Recognized Specialist Receives the 2016 ACCC Clinical Research Award

Michael O’Connell, MD, Honored at the 33rd National Oncology Conference

ROCKVILLE, MD. – Michael O’Connell, MD, received the Association of Community Cancer Centers (ACCC) 2016 Clinical Research Award in recognition of the significant and positive impact of his research on the oncology patient, family, and the community. ACCC President Jennie R. Crews, MD, MMM, FACP, accepted the award on Dr. O’Connell’s behalf on Thursday, October 20, 2016, at the 33rd National Oncology Conference, in St. Louis, Missouri.

Dr. O’Connell is an internationally recognized specialist in the treatment of gastrointestinal tract cancers, and a prolific researcher who has authored or co-authored more than 200 peer-reviewed journal articles, 150 scientific abstracts, and 25 textbook chapters in his field.

Dr. O'Connell was among a select group of cancer specialists invited to the White House in 1996 for President Clinton's announcement of major changes in the U.S. Food and Drug Administration (FDA) policy for approval of oncology drugs. He was selected to participate in the National Dialogue on Cancer chaired by President and Mrs. George H. Bush and the 2001 World Summit Against Cancer in Paris, France.

He has helped direct numerous studies that have resulted in better treatment protocols for cancer of the colon and rectum, and is currently a leader of a national study on the efficacy of a new anti-angiogenesis therapy combined with standard chemotherapy in patients who have already had surgery for stage II or stage III colon cancer.

Dr. O'Connell currently serves as an associate chairman of the National Surgical Adjuvant Breast and Bowel Project (NSABP), as a member of the American Society of Clinical Oncology and the American Association for Cancer Research, and on the Board of Directors for the Coalition of National Cancer Cooperative Groups. He is also a member of the National Cancer Institute steering committee for gastrointestinal cancer cooperative group clinical trials.

Among the past winners of the prestigious annual ACCC Clinical Research Award are Patricia Layton, RN, BSN; Nicholas J. Petrelli, MD, FACS; David S. Alberts, MD; Charles M. Balch, MD, FACS; Al B. Benson III, MD, FACP; Donna Berry, PhD, RN, AOCN®, FAAN; David H. Johnson, MD; Lillian M. Nail, PhD, RN, FAAN; Daniel D. Von Hoff, MD, FACP; Saul Rivkin, MD; Henry Lynch, MD; and Vincent DeVita, Jr., MD.


About the Association of Community Cancer Centers


The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care community. Founded in 1974, ACCC is a powerful network of 25,000 multidisciplinary practitioners from 2,100 hospitals and practices nationwide. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve — so has ACCC — adapting its resources to meet the changing needs of the entire oncology care team. For more information, visit accc-cancer.org or call 301.984.9496. Follow us on Facebook, Twitter, and LinkedIn; read our blog, ACCCBuzz; and tune in to our podcast, CANCER BUZZ.